Iman van den Bout

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Venues

Clinical and translational science

Cancer cell international

International journal of molecular sciences

Biomedicines

University of Pretoria

University of Amsterdam (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pretoria Oct 01 2016

South Africa

Lecturer :: Physiology

Education History

University of Amsterdam Feb 01 2000 - Apr 13 2008

Netherlands

PHD

Publications

Simone Grobbelaar, Anne Elisabeth Mercier, Iman van den Bout, Chrisna Durandt, Michael Sean Pepper
Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. Clinical and translational science 17 (1) (2024)
Simone Grobbelaar, Anne Elisabeth Mercier, Iman van den Bout, Chrisna Durandt, Michael Sean Pepper
Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. Clinical and translational science 17 (1) (2024)
Simone Grobbelaar, Anne E Mercier, Iman van den Bout, Chrisna Durandt, Michael S Pepper
Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. Clinical and translational science (2023)
Simone Grobbelaar, Anne E Mercier, Iman van den Bout, Chrisna Durandt, Michael S Pepper
Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. Clinical and translational science (2023)
Keith N Ncube, Tamarin Jurgens, Vanessa Steenkamp, Allan D Cromarty, Iman van den Bout, Werner Cordier
Comparative Evaluation of the Cytotoxicity of Doxorubicin in BT-20 Triple-Negative Breast Carcinoma Monolayer and Spheroid Cultures. Biomedicines 11 (5) (2023)
Simone Grobbelaar, Anne E Mercier, Iman van den Bout, Chrisna Durandt, Michael S Pepper
Considerations for enhanced mesenchymal stromal/stem cell myogenic commitment in vitro. Clinical and translational science (2023)
Udochi F Azubuike, Claire L Newton, Iman van den Bout
Lack of Oestrogen Receptor Expression in Breast Cancer Cells Does Not Correlate with Kisspeptin Signalling and Migration. International journal of molecular sciences 23 (15) (2022)
Ross C Anderson, Sharika Hanyroup, Yong Bhum Song, Zulfiah Mohamed-Moosa, Iman van den Bout, Alexis C Schwulst, Ursula B Kaiser, Robert P Millar, Claire L Newton
Functional Rescue of Inactivating Mutations of the Human Neurokinin 3 Receptor Using Pharmacological Chaperones. International journal of molecular sciences 23 (9) (2022)
Rustelle Janse van Vuuren, Mandie Botes, Tamarin Jurgens, Anna Margaretha Joubert, Iman van den Bout
Correction to: Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization. Cancer cell international 20 (2020)
Rustelle Janse van Vuuren, Mandie Botes, Tamarin Jurgens, Anna Margaretha Joubert, Iman van den Bout
Novel sulphamoylated 2-methoxy estradiol derivatives inhibit breast cancer migration by disrupting microtubule turnover and organization. Cancer cell international 19 (2019)
Mandie Botes, Tamarin Jurgens, Zohreh Riahi, Michelle Visagie, Rustelle Janse van Vuuren, Anna Margaretha Joubert, Iman van den Bout
A novel non-sulphamoylated 2-methoxyestradiol derivative causes detachment of breast cancer cells by rapid disassembly of focal adhesions. Cancer cell international 18 (2018)

Iman van den Bout.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Iman van den Bout